Bend Bioscience Brand Emerges from CoreRx and Societal CDMO Merger
![Bend Bioscience Brand Emerges from CoreRx and Societal CDMO Merger](https://investorshangout.com/images/blog/ihnews-Bend%20Bioscience%20Brand%20Emerges%20from%20CoreRx%20and%20Societal%20CDMO%20Merger.jpg)
Bend Bioscience Brand Unites CoreRx and Societal CDMO
In an exciting development, CoreRx, Societal CDMO, and Bend Bioscience have joined forces, merging under the Bend Bioscience brand. This collaboration combines the strengths and legacies of three well-respected organizations into one cohesive entity focused on delivering a full suite of contract development and manufacturing organization (CDMO) services.
Strength Through Unification
The selection of the Bend Bioscience name symbolizes the company’s dedication to innovation and superior customer service—a reputation built over years of excellence. This unification honors the rich histories of CoreRx and Societal CDMO, with their expertise serving as foundational elements in the new company's framework.
CoreRx’s Innovative Solutions
CoreRx has established itself as a leader in formulation development, known for creating tailor-made solutions to tackle complex challenges in the pharmaceutical landscape. Its deep understanding of innovative drug delivery systems and elaborate formulations will play a vital role in the extended services offered by Bend Bioscience.
Societal CDMO’s Manufacturing Expertise
On the other hand, Societal CDMO brings significant experience in scalable manufacturing and commercial production. With a strong commitment to maintaining excellence and reliability, their operations in cGMP manufacturing, packaging, and efficient supply chain management will enhance the scientific and technical capabilities of the newly integrated organization.
The Vision for Bend Bioscience
Owen Murray, CEO of Bend Bioscience, stated, "Choosing Bend Bioscience as our unified brand reflects the scientific excellence and innovative spirit inherent in all three companies. This merger transcends resource sharing; instead, it is about leveraging the complementary strengths of Advanced formulation capabilities from CoreRx, manufacturing expertise from Societal CDMO, and our innovative research at Bend Bioscience. Together, we aim to offer unmatched value and service to our clients and their patients."
Ready to Meet Future Challenges
By consolidating their efforts under the Bend Bioscience name, the new organization is strategically positioned to enhance operational efficiencies and harness their combined expertise. This will enable them to provide high-quality services designed to expedite the delivery of life-saving therapies to the marketplace.
About Bend Bioscience
Bend Bioscience is a leading CDMO formed through the merger of CoreRx, Societal CDMO, and Bend Bioscience itself. The organization specializes in delivering innovative solutions for every stage of drug development and manufacturing. With a focus on quality, science, and exceptional service, Bend Bioscience boasts advanced facilities across various locations, serving clients across the globe with a comprehensive array of capabilities. Their mission is to partner with clients to translate complex molecules into effective medicines.
For further information or media inquiries, please reach out to:
Media Contact Information
Melissa Sullivan
Director of Marketing + Communications
Bend Bioscience
Email: [email protected]
Frequently Asked Questions
What is the significance of the Bend Bioscience merger?
The merger combines CoreRx and Societal CDMO under Bend Bioscience, creating a stronger CDMO service provider.
How does this merger benefit clients?
This unification enhances capabilities, providing a comprehensive pathway for drug development and manufacturing.
Who is leading Bend Bioscience post-merger?
Owen Murray is the CEO of Bend Bioscience, promoting innovation and operational excellence.
What areas of expertise does Bend Bioscience cover?
Bend Bioscience specializes in formulation development, scalable manufacturing, and supply chain management.
Where are the facilities of Bend Bioscience located?
Bend Bioscience operates state-of-the-art facilities across various locations, enhancing global service delivery.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Related Articles
- NanoXplore Webcast to Discuss Q4 and Year-End Financials
- GoHealth Expands by Acquiring e-TeleQuote in Medicare Market
- ASUS Unveils Innovative Vivobook S 15 and ProArt PZ13 Laptops
- HARIBO Launches Fall Edition Goldbears and Halloween Treats
- Novartis Expands Radioligand Therapy Facilities in the US
- DICK'S Sporting Goods Expands Growth Outlook After Q2 Success
- Neptune Flood Achieves 200,000 Policies and $250 Million Premium
- Taylor Morrison Expands with Two New Communities in Gwinnett
- IHH Healthcare Acquires Island Hospital for RM 3.92 Billion
- Berkshire Hathaway: Buffett's Vision and Future Considerations
- Understanding Roth Conversion: Tax Implications Explained
- Market Fluctuations Amid Economic Concerns and Data
- Waterdrop Inc. Reports Q2 2024 Financial Results and Dividend
- Jad Lahoud Named Partner and Board Director at eMerge Americas
- Dollar Tree Faces Challenges with Q2 Results and Outlook
- Dollar Tree Adjusts Annual Forecast Amid Weak Demand Challenges
- Understanding the Volkswagen Law: Governance Behind the Scenes
- SitePro™ Rentals Expands Its Presence with Sherman Branch
- Global Hard Gelatin Capsules Market Growth and Insights
- Agricultural Equipment Market Growth and Innovations Ahead
- Nykredit Realkredit A/S Adjusts Coupon Rates from September 2024
- Local Soda Brands Flourish Amid Coca-Cola and Pepsi Boycott
- India Stocks Decline; Nifty 50 and BSE Sensex Performance Insights
- TSMC and Samsung's Positive AI Outlook at Trade Show
- Dollar Tree Reports Earnings Miss and Revenue Shortfall
Recent Articles
- Innovative Food Holdings Closes Deal for igourmet.com Business
- Brain Aneurysm Foundation Unveils 2024 Research Grant Winners
- Neptune Flood Achieves 200,000 Policies and $250 Million Premium
- Amber Wright Appointed Head of EMEA Sales at R.J. O'Brien
- Epson Launches High-Performance Check Scanners for Banking
- Antitrust Trial Against Google Highlights Digital Ad Dynamics
- HBCU+ College netWORK Empowering Students in Gaming Careers
- Barratt Developments Sees Profits Fall Amid Market Challenges
- Polymer Fillers Market Expected to Exceed USD 65 Billion Growth
- Tom Lee Predicts a 7-10% S&P 500 Correction Ahead
- Auction Results for 2.25% DGB Bonds: 2026 and 2033
- Angel Studios Gains $10 Million in Five Days to Innovate Entertainment
- S&P 500 and Nasdaq Navigate Critical Market Levels Effectively
- Synthetic Dyes Market Expected to Reach $9.1 Billion by 2029
- Unlocking Opportunities: Next Generation Medical Writing Course
- Crédit Agricole Assurances Issues €750 Million Tier 2 Notes
- Amorepacific Museum Unveils Groundbreaking Elmgreen & Dragset Exhibition
- China Shipyards Merge to Strengthen Maritime Capabilities
- Thai King Supports New Cabinet Under PM Paetongtarn Shinawatra
- HP to Receive $50 Million Funding for Semiconductor Tech Boost
- Upsolve Secures $4.2 Million Grant to Develop Financial Counsel
- Highland Opportunities and Income Fund Monthly Distribution Update
- Milan Laser Hair Removal Supports Veterans Through Makeover Show
- Class Action Filed Against DXC Technology Company - What You Need to Know
- Smart-Connected Pet Collars Market Set for Significant Growth